Covered recipient · General Payments record
NATHAN CAMPBELL
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,815.72
- Reported across 94 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $447.21 | 17 |
| Education | $74.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $210.15 | 10 |
| BOSTON SCIENTIFIC CORPORATION | $119.50 | 2 |
| Janssen Biotech, Inc. | $113.93 | 4 |
| Janssen Scientific Affairs, LLC | $49.19 | 1 |
| Lilly USA, LLC | $29.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.15 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103409989 | CMS |
| ABBVIE INC. | $5.02 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103409991 | CMS |
| ABBVIE INC. | $126.58 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103409993 | CMS |
| ABBVIE INC. | $15.65 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103409995 | CMS |
| ABBVIE INC. | $6.42 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103409997 | CMS |
| ABBVIE INC. | $5.68 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103409999 | CMS |
| ABBVIE INC. | $3.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410001 | CMS |
| ABBVIE INC. | $5.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410003 | CMS |
| ABBVIE INC. | $19.28 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410005 | CMS |
| ABBVIE INC. | $8.37 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103410007 | CMS |
| Boston Scientific Corporation | $37.50 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092752414 | CMS |
| Boston Scientific Corporation | $82.00 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092752416 | CMS |
| Janssen Biotech, Inc. | $15.42 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078832776 | CMS |
| Janssen Biotech, Inc. | $5.51 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078831530 | CMS |
| Janssen Biotech, Inc. | $74.99 | 04/17/2024 | Education | Undisputed | 01/23/2026 | 1078833410 | CMS |
| Janssen Biotech, Inc. | $18.01 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078831909 | CMS |
| Janssen Scientific Affairs, LLC | $49.19 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078861819 | CMS |
| Lilly USA, LLC | $29.43 | 12/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135283213 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.